Literature DB >> 25325416

Cerebrospinal fluid disturbances after 381 consecutive craniotomies for intracranial tumors in pediatric patients.

Sayied Abdol Mohieb Hosainey1, Benjamin Lassen, Eirik Helseth, Torstein R Meling.   

Abstract

OBJECT: The aim of this study was to investigate the incidence of CSF disturbances before and after intracranial surgery for pediatric brain tumors in a large, contemporary, single-institution consecutive series.
METHODS: All pediatric patients (those < 18 years old), from a well-defined population of 3.0 million inhabitants, who underwent craniotomies for intracranial tumors at Oslo University Hospital in Rikshospitalet between 2000 and 2010 were included. The patients were identified from the authors' prospectively collected database. A thorough review of all medical charts was performed to validate all the database data.
RESULTS: Included in the study were 381 consecutive craniotomies, performed on 302 patients (50.1% male, 49.9% female). The mean age of the patients in the study was 8.63 years (range 0-17.98 years). The follow-up rate was 100%. Primary craniotomies were performed in 282 cases (74%), while 99 cases (26%) were secondary craniotomies. Tumors were located supratentorially in 249 cases (65.3%), in the posterior fossa in 105 (27.6%), and in the brainstem/diencephalon in 27 (7.1%). The surgical approach was supratentorial in 260 cases (68.2%) and infratentorial in 121 (31.8%). Preoperative hydrocephalus was found in 124 cases (32.5%), and 71 (86.6%) of 82 achieved complete cure with tumor resection only. New-onset postoperative hydrocephalus was observed in 9 (3.5%) of 257 cases. The rate of postoperative CSF leaks was 6.3%.
CONCLUSIONS: Preoperative hydrocephalus was found in 32.5% of pediatric patients with brain tumors treated using craniotomies. Tumor resection alone cured preoperative hydrocephalus in 86.6% of cases and the incidence of new-onset hydrocephalus after craniotomy was only 3.5%.

Entities:  

Keywords:  CI = confidence interval; DNET = dysembryoplastic neuroepithelial tumor; ETV = endoscopic third ventriculostomy; EVD = external ventricular drain; OR = odds ratio; PNET = primitive neuroectodermal tumor; VP = ventriculo-peritoneal; complications; craniotomy; endoscopic third ventriculostomy; external ventricular drain; hydrocephalus; intracranial tumor; oncology; surgical mortality

Mesh:

Year:  2014        PMID: 25325416     DOI: 10.3171/2014.8.PEDS13585

Source DB:  PubMed          Journal:  J Neurosurg Pediatr        ISSN: 1933-0707            Impact factor:   2.375


  5 in total

1.  The effect of tumor removal via craniotomies on preoperative hydrocephalus in adult patients with intracranial tumors.

Authors:  Sayied Abdol Mohieb Hosainey; Benjamin Lassen; John K Hald; Eirik Helseth; Torstein R Meling
Journal:  Neurosurg Rev       Date:  2018-08-17       Impact factor: 3.042

2.  Single-Center Retrospective Analysis of Risk Factors for Hydrocephalus After Lateral Ventricular Tumor Resection.

Authors:  Chengda Zhang; Lingli Ge; Zhengwei Li; Tingbao Zhang; Jincao Chen
Journal:  Front Surg       Date:  2022-06-16

3.  Stereotactic Placement of Intratumoral Catheters for Continuous Infusion Delivery of Herpes Simplex Virus -1 G207 in Pediatric Malignant Supratentorial Brain Tumors.

Authors:  Joshua D Bernstock; Zachary Wright; Asim K Bag; Florian Gessler; George Yancey Gillespie; James M Markert; Gregory K Friedman; James M Johnston
Journal:  World Neurosurg       Date:  2018-11-24       Impact factor: 2.104

4.  Risk factors for new-onset shunt-dependency after craniotomies for intracranial tumors in adult patients.

Authors:  Sayied Abdol Mohieb Hosainey; Benjamin Lassen; John K Hald; Eirik Helseth; Torstein R Meling
Journal:  Neurosurg Rev       Date:  2017-07-03       Impact factor: 3.042

5.  Risk factors for hydrocephalus following fourth ventricle tumor surgery: A retrospective analysis of 121 patients.

Authors:  Tengyun Chen; Yanming Ren; Chenghong Wang; Bowen Huang; Zhigang Lan; Wenke Liu; Yan Ju; Xuhui Hui; Yuekang Zhang
Journal:  PLoS One       Date:  2020-11-17       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.